Genix Pharmaceuticals Corporation

Price Chart

Risk-Adjusted Performance

Genix Pharmaceuticals Corporation (GENPF) Price Performance

Genix Pharmaceuticals Corporation (GENPF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $0.01.

Over the past year, GENPF has traded between a low of $0.01 and a high of $0.04. The stock has lost 64.8% over this period. It is currently 64.8% below its 52-week high.

Genix Pharmaceuticals Corporation has a market capitalization of $846,505.

About Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.